---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036852"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:17:39.789120+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics sets 2024 Annual Meeting for Nov 26; Oct 4 record date; Sep 27 deadline for proposals

## Summary
- 2024 Annual Meeting scheduled for Tuesday, November 26, 2024.
- Record date for voting set at close of business on October 4, 2024.
- Stockholder proposals under Rule 14a-8 must be received by September 27, 2024.
- Director nominations and non-proxy proposals also due by September 27, 2024.
- Address for submissions: Corporate Secretary, Vivos Therapeutics, Inc., 7921 Southpark Plaza, Suite 210, Littleton, CO 80120.

## SEC filing metadata
- accession: 0001493152-24-036852
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/0001493152-24-036852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036852
- JSON: https://secwatch.observer/filing/0001493152-24-036852.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036852.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.